USMLE Step 2 CK: Haematology, Oncology, Hemostasis, DVT/PE, Anticoagulation, HIT, DIC, TTP—Distinguishing and Treating

What This Is and Why It Matters for USMLE

Hemostasis: DVT/PE Anticoagulation, HIT, DIC, TTP is a critical topic for USMLE Steps 1, 2 CK, and 3. It's high-yield for Step 1 and Step 2 CK, appearing in basic science, clinical, and management contexts. Understanding the pathophysiology, diagnostic approach, and treatment of these conditions is essential for managing patients with bleeding and clotting disorders.

High-Yield Facts (What You Must Memorize)

• Pathophysiology:
  • DVT: clot formation in deep veins, often due to stasis, hypercoagulability, or vascular injury
  • PE: clot embolization to pulmonary arteries, often fatal if not treated promptly
  • HIT: immune-mediated reaction to heparin, leading to thrombocytopenia and thrombosis
  • DIC: widespread clotting and bleeding due to consumption of clotting factors
  • TTP: thrombotic microangiopathy, characterized by microvascular thrombi and thrombocytopenia
• Classic presentation and physical exam findings:
  • DVT: pain, swelling, warmth, and redness in affected limb
  • PE: acute onset of dyspnea, chest pain, and tachycardia
  • HIT: thrombocytopenia, often with thrombosis
  • DIC: bleeding, thrombocytopenia, and organ dysfunction
  • TTP: microangiopathic hemolytic anemia, thrombocytopenia, and renal failure
• Diagnostic approach:
  • DVT: ultrasound, CT angiography, or MRI
  • PE: CT pulmonary angiography, ventilation-perfusion scan, or D-dimer
  • HIT: heparin-platelet factor 4 antibody test
  • DIC: laboratory tests, including PT, aPTT, fibrinogen, and D-dimer
  • TTP: laboratory tests, including ADAMTS13 activity and platelet count
• First-line treatment and management:
  • DVT: anticoagulation with LMWH or warfarin
  • PE: anticoagulation with LMWH or warfarin, often with thrombolytic therapy
  • HIT: heparin cessation, anticoagulation with alternative agents
  • DIC: anticoagulation, often with fresh frozen plasma and platelet transfusions
  • TTP: plasma exchange, corticosteroids, and anticoagulation

Clinical Pearls & Buzzwords

• Heparin-induced thrombocytopenia (HIT)
• Disseminated intravascular coagulation (DIC)
• Thrombotic thrombocytopenic purpura (TTP)
• Activated protein C resistance (APCR)
• Factor V Leiden mutation

Step-by-Step Clinical Reasoning

1. Identify the syndrome or presentation.
2. Generate a differential (most likely and must-not-miss).
3. Order appropriate initial tests.
4. Interpret results.
5. Initiate treatment and monitoring.

Missing a life-threatening complication, such as PE or DIC, can lead to devastating consequences.

Common Mistakes & Exam Traps

• The mistake: Failing to consider HIT in a patient on heparin, leading to thrombocytopenia and thrombosis.
• Why it happens: Misunderstanding the pathophysiology of HIT or failing to recognize the clinical presentation.
• How to avoid it: Consider HIT in any patient on heparin with thrombocytopenia or thrombosis.

• Exam board insight: The examiners will penalize students for failing to consider HIT in a patient on heparin.

• The mistake: Failing to diagnose DIC in a patient with bleeding and thrombosis.

• Why it happens: Misinterpreting laboratory tests or failing to consider the clinical presentation.
• How to avoid it: Consider DIC in any patient with bleeding and thrombosis, and order appropriate laboratory tests.
• Exam board insight: The examiners will penalize students for failing to diagnose DIC in a patient with bleeding and thrombosis.

How It’s Tested on USMLE

• Step 1: Basic science vignette, such as a molecular mechanism or pathology slide, related to hemostasis and thrombosis.
• Step 2 CK: Clinical vignette, such as a patient with DVT or PE, requiring diagnosis and treatment.
• Step 3: Similar to Step 2 CK, with a focus on prognosis, risk factors, and management.

CCS (Step 3) Relevance (If Applicable)

• Initial orders: Order a D-dimer and CT pulmonary angiography in a patient with suspected PE.
• Monitoring and follow-up: Monitor the patient's vital signs and laboratory tests, and follow up with a repeat CT pulmonary angiography in 24 hours.
• Common mistakes: Failing to order a D-dimer or CT pulmonary angiography, or delaying treatment.

Practice Questions (3-5 single-best-answer)

Question 1: A 45-year-old woman presents with sudden onset of dyspnea and chest pain. She has a history of deep vein thrombosis. Which of the following is the most likely diagnosis?

Options: A) Pulmonary embolism, B) Acute coronary syndrome, C) Pneumonia, D) Asthma exacerbation

Answer: A) Pulmonary embolism

Explanation: The patient's history of deep vein thrombosis and sudden onset of dyspnea and chest pain are consistent with pulmonary embolism.

Question 2: A 30-year-old man presents with thrombocytopenia and thrombosis after receiving heparin for a medical condition. Which of the following is the most likely diagnosis?

Options: A) Heparin-induced thrombocytopenia, B) Disseminated intravascular coagulation, C) Thrombotic thrombocytopenic purpura, D) Idiopathic thrombocytopenic purpura

Answer: A) Heparin-induced thrombocytopenia

Explanation: The patient's thrombocytopenia and thrombosis after receiving heparin are consistent with heparin-induced thrombocytopenia.

Question 3: A 50-year-old woman presents with bleeding and thrombosis. Which of the following is the most likely diagnosis?

Options: A) Disseminated intravascular coagulation, B) Thrombotic thrombocytopenic purpura, C) Heparin-induced thrombocytopenia, D) Idiopathic thrombocytopenic purpura

Answer: A) Disseminated intravascular coagulation

Explanation: The patient's bleeding and thrombosis are consistent with disseminated intravascular coagulation.

Quick Reference Card (60-Second Summary)

• DVT: anticoagulation with LMWH or warfarin
• PE: anticoagulation with LMWH or warfarin, often with thrombolytic therapy
• HIT: heparin cessation, anticoagulation with alternative agents
• DIC: anticoagulation, often with fresh frozen plasma and platelet transfusions
• TTP: plasma exchange, corticosteroids, and anticoagulation
• ADAMTS13 activity: <10% in TTP
• Platelet count: <20,000/?L in TTP

If You Get Stuck on Test Day

• Eliminate obviously wrong answers: Consider the patient's presentation, history, and laboratory tests.
• Use the "next best step" hierarchy: Consider the least invasive and most specific test or treatment.
• For Step 3 CCS: Order basic laboratory tests, vital signs, and IV access when unsure.

Related USMLE Topics

• Thrombophilia: connects to DVT, PE, and HIT
• Bleeding disorders: connects to DIC and TTP
• Anticoagulation therapy: connects to DVT, PE, and HIT